XML 97 R52.htm IDEA: XBRL DOCUMENT v3.8.0.1
Supplemental Condensed Consolidating Financial Information (Tables)
12 Months Ended
Dec. 31, 2017
Condensed Financial Information [Abstract]  
Condensed Consolidating Statements of Income
Condensed Statements of Operations
 
Year Ended December 31,
 
2017
 
2016
 
2015
 
(In millions)
Revenue:
 
 
 
 
 
Management fees
$
1,317

 
$
1,062

 
$
914

Investment income and other revenue
16

 
16

 
17

Total revenue
1,333

 
1,078

 
931

Expenses:
 
 
 
 
 

Medical care costs
16

 
73

 
55

General and administrative expenses
1,082

 
899

 
797

Depreciation and amortization
93

 
95

 
82

Impairment losses
39

 

 

Restructuring and separation costs
153

 

 

Total operating expenses
1,383

 
1,067

 
934

Operating (loss) income
(50
)
 
11

 
(3
)
Interest expense
117

 
101

 
66

Other income
(61
)
 

 

Loss before income taxes and equity in net income of subsidiaries
(106
)
 
(90
)
 
(69
)
Income tax expense (benefit)
8

 
(24
)
 
(21
)
Net loss before equity in net income of subsidiaries
(114
)
 
(66
)
 
(48
)
Equity in net (loss) income of subsidiaries
(398
)
 
118

 
191

Net (loss) income
$
(512
)
 
$
52

 
$
143

CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS
 
Year Ended December 31, 2017
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Revenue:
 
 
 
 
 
 
 
 
 
Total revenue
$
1,333

 
$
194

 
$
19,712

 
$
(1,356
)
 
$
19,883

Expenses:
 
 
 
 
 
 
 
 
 
Medical care costs
16

 

 
17,058

 
(1
)
 
17,073

Cost of service revenue

 
171

 
321

 

 
492

General and administrative expenses
1,082

 
17

 
1,850

 
(1,355
)
 
1,594

Premium tax expenses

 

 
438

 

 
438

Depreciation and amortization
93

 
1

 
43

 

 
137

Impairment losses
39

 
28

 
403

 

 
470

Restructuring and separation costs
153

 
8

 
73

 

 
234

Total operating expenses
1,383

 
225

 
20,186

 
(1,356
)
 
20,438

Operating loss
(50
)
 
(31
)
 
(474
)
 

 
(555
)
Interest expense
117

 

 
1

 

 
118

Other income
(61
)
 

 

 

 
(61
)
Loss before income taxes
(106
)
 
(31
)
 
(475
)
 

 
(612
)
Income tax expense (benefit)
8

 
(21
)
 
(87
)
 

 
(100
)
Net loss before equity in earnings of subsidiaries
(114
)
 
(10
)
 
(388
)
 

 
(512
)
Equity in net earnings of subsidiaries
(398
)
 
(156
)
 

 
554

 

Net loss
$
(512
)
 
$
(166
)
 
$
(388
)
 
$
554

 
$
(512
)

 
Year Ended December 31, 2016
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Revenue:
 
 
 
 
 
 
 
 
 
Total revenue
$
1,078

 
$
202

 
$
17,584

 
$
(1,082
)
 
$
17,782

Expenses:
 
 
 
 
 
 
 
 
 
Medical care costs
73

 

 
14,702

 
(1
)
 
14,774

Cost of service revenue

 
174

 
311

 

 
485

General and administrative expenses
899

 
16

 
1,559

 
(1,081
)
 
1,393

Premium tax expenses

 

 
468

 

 
468

Health insurer fees

 

 
217

 

 
217

Depreciation and amortization
95

 
1

 
43

 

 
139

Total operating expenses
1,067

 
191

 
17,300

 
(1,082
)
 
17,476

Operating income
11

 
11

 
284

 

 
306

Total other expenses, net
101

 

 

 

 
101

(Loss) income before income taxes
(90
)
 
11

 
284

 

 
205

Income tax (benefit) expense
(24
)
 
3

 
174

 

 
153

Net (loss) income before equity in earnings of subsidiaries
(66
)
 
8

 
110

 

 
52

Equity in net earnings of subsidiaries
118

 
1

 

 
(119
)
 

Net income
$
52

 
$
9

 
$
110

 
$
(119
)
 
$
52

 
Year Ended December 31, 2015
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Revenue:
 
 
 
 
 
 
 
 
 
Total revenue
$
931

 
$
195

 
$
13,980

 
$
(928
)
 
$
14,178

Expenses:
 
 
 
 
 
 
 
 
 
Medical care costs
55

 

 
11,740

 
(1
)
 
11,794

Cost of service revenue

 
140

 
53

 

 
193

General and administrative expenses
797

 
31

 
1,245

 
(927
)
 
1,146

Premium tax expenses

 

 
397

 

 
397

Health insurer fees

 

 
157

 

 
157

Depreciation and amortization
82

 
1

 
21

 

 
104

Total operating expenses
934

 
172

 
13,613

 
(928
)
 
13,791

Operating (loss) income
(3
)
 
23

 
367

 

 
387

Total other expenses, net
66

 

 
(1
)
 

 
65

(Loss) income before income taxes
(69
)
 
23

 
368

 

 
322

Income tax (benefit) expense
(21
)
 
7

 
193

 

 
179

Net (loss) income before equity in earnings of subsidiaries
(48
)
 
16

 
175

 

 
143

Equity in net earnings of subsidiaries
191

 
(1
)
 

 
(190
)
 

Net income
$
143

 
$
15

 
$
175

 
$
(190
)
 
$
143

Condensed Consolidating Statements of Comprehensive Income
CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE (LOSS) INCOME
 
Year Ended December 31, 2017
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
 
 
 
 
 
 
 
 
 
 
(In millions)
Net loss
$
(512
)
 
$
(166
)
 
$
(388
)
 
$
554

 
$
(512
)
Other comprehensive loss, net of tax
(3
)
 

 
(2
)
 
2

 
(3
)
Comprehensive loss
$
(515
)
 
$
(166
)
 
$
(390
)
 
$
556

 
$
(515
)
 
Year Ended December 31, 2016
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
 
 
 
 
 
 
 
 
 
 
(In millions)
Net income
$
52

 
$
9

 
$
110

 
$
(119
)
 
$
52

Other comprehensive income, net of tax
2

 

 
1

 
(1
)
 
2

Comprehensive income
$
54

 
$
9

 
$
111

 
$
(120
)
 
$
54

 
Year Ended December 31, 2015
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
 
 
 
 
 
 
 
 
 
 
(In millions)
Net income
$
143

 
$
15

 
$
175

 
$
(190
)
 
$
143

Other comprehensive loss, net of tax
(3
)
 

 
(3
)
 
3

 
(3
)
Comprehensive income
$
140

 
$
15

 
$
172

 
$
(187
)
 
$
140

Condensed Consolidating Balance Sheet
Condensed Balance Sheets
 
December 31,
 
2017
 
2016
 
(In millions, except per-share data)
ASSETS
Current assets:
 

 
 
Cash and cash equivalents
$
504

 
$
86

Investments
192

 
178

Restricted investments
169

 

Receivables
2

 
2

Income taxes refundable
16

 
17

Due from affiliates
148

 
104

Prepaid expenses and other current assets
87

 
58

Derivative asset
522

 
267

Total current assets
1,640

 
712

Property, equipment, and capitalized software, net
223

 
301

Goodwill and intangible assets, net
15

 
58

Investments in subsidiaries
2,306

 
2,609

Deferred income taxes
17

 
10

Advances to related parties and other assets
32

 
48

 
$
4,233

 
$
3,738

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
 
 
 
Medical claims and benefits payable
$
3

 
$
1

Accounts payable and accrued liabilities
178

 
146

Current portion of long-term debt
653

 
472

Derivative liability
522

 
267

Total current liabilities
1,356

 
886

Senior notes
1,318

 
975

Lease financing obligations
198

 
198

Deferred income taxes

 
11

Other long-term liabilities
24

 
19

Total liabilities
2,896

 
2,089

Stockholders’ equity:
 
 
 
Common stock, $0.001 par value; 150 shares authorized; outstanding:
 
 


60 shares at December 31, 2017 and 57 shares at December 31, 2016

 

Preferred stock, $0.001 par value; 20 shares authorized, no shares issued and outstanding

 

Additional paid-in capital
1,044

 
841

Accumulated other comprehensive loss
(5
)
 
(2
)
Retained earnings
298

 
810

Total stockholders’ equity
1,337

 
1,649

 
$
4,233

 
$
3,738

MOLINA HEALTHCARE, INC.
CONDENSED CONSOLIDATING BALANCE SHEETS
 
December 31, 2017
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
ASSETS
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
504

 
$
28

 
$
2,654

 
$

 
$
3,186

Investments
192

 

 
2,332

 

 
2,524

Restricted investments
169

 

 

 

 
169

Receivables
2

 
30

 
839

 

 
871

Income tax refundable
16

 
(8
)
 
46

 

 
54

Due from (to) affiliates
148

 
(6
)
 
(142
)
 

 

Prepaid expenses and other current assets
87

 
22

 
92

 
(16
)
 
185

Derivative asset
522

 

 

 

 
522

Total current assets
1,640

 
66

 
5,821

 
(16
)
 
7,511

Property, equipment, and capitalized software, net
223

 
33

 
86

 

 
342

Deferred contract costs

 
101

 

 

 
101

Goodwill and intangible assets, net
15

 
43

 
197

 

 
255

Restricted investments

 

 
119

 

 
119

Investment in subsidiaries, net
2,306

 
82

 

 
(2,388
)
 

Deferred income taxes
17

 

 
101

 
(15
)
 
103

Other assets
32

 
2

 
7

 
(1
)
 
40

 
$
4,233

 
$
327

 
$
6,331

 
$
(2,420
)
 
$
8,471

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
 
 
 
 
 
 
 
 
 
Medical claims and benefits payable
$
3

 
$

 
$
2,189

 
$

 
$
2,192

Amounts due government agencies

 
1

 
1,541

 

 
1,542

Accounts payable and accrued liabilities
178

 
40

 
148

 

 
366

Deferred revenue

 
49

 
233

 

 
282

Current portion of long-term debt
653

 

 
16

 
(16
)
 
653

Derivative liability
522

 

 

 

 
522

Total current liabilities
1,356

 
90

 
4,127

 
(16
)
 
5,557

Long-term debt
1,516

 

 

 

 
1,516

Deferred income taxes

 
15

 

 
(15
)
 

Other long-term liabilities
24

 
2

 
36

 
(1
)
 
61

Total liabilities
2,896

 
107

 
4,163

 
(32
)
 
7,134

Total stockholders’ equity
1,337

 
220

 
2,168

 
(2,388
)
 
1,337

 
$
4,233

 
$
327

 
$
6,331

 
$
(2,420
)
 
$
8,471


MOLINA HEALTHCARE, INC.
CONDENSED CONSOLIDATING BALANCE SHEETS
 
December 31, 2016
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
ASSETS
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
86

 
$
6

 
$
2,727

 
$

 
$
2,819

Investments
178

 

 
1,580

 

 
1,758

Receivables
2

 
34

 
938

 

 
974

Income tax refundable
17

 
4

 
18

 

 
39

Due from (to) affiliates
104

 
(5
)
 
(99
)
 

 

Prepaid expenses and other current assets
58

 
30

 
43

 

 
131

Derivative asset
267

 

 

 

 
267

Total current assets
712

 
69

 
5,207

 

 
5,988

Property, equipment, and capitalized software, net
301

 
46

 
107

 

 
454

Deferred contract costs

 
86

 

 

 
86

Goodwill and intangible assets, net
58

 
73

 
629

 

 
760

Restricted investments

 

 
110

 

 
110

Investment in subsidiaries, net
2,609

 
246

 

 
(2,855
)
 

Deferred income taxes
10

 

 

 

 
10

Other assets
48

 
3

 
6

 
(16
)
 
41

 
$
3,738

 
$
523

 
$
6,059

 
$
(2,871
)
 
$
7,449

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
 
 
 
 
 
 
 
 
 
Medical claims and benefits payable
$
1

 
$

 
$
1,928

 
$

 
$
1,929

Amounts due government agencies

 

 
1,202

 

 
1,202

Accounts payable and accrued liabilities
146

 
34

 
205

 

 
385

Deferred revenue

 
40

 
275

 

 
315

Current portion of long-term debt
472

 

 

 

 
472

Derivative liability
267

 

 

 

 
267

Total current liabilities
886

 
74

 
3,610

 

 
4,570

Long-term debt
1,173

 

 
16

 
(16
)
 
1,173

Deferred income taxes
11

 
39

 
(35
)
 

 
15

Other long-term liabilities
19

 
1

 
22

 

 
42

Total liabilities
2,089

 
114

 
3,613

 
(16
)
 
5,800

Total stockholders’ equity
1,649

 
409

 
2,446

 
(2,855
)
 
1,649

 
$
3,738

 
$
523

 
$
6,059

 
$
(2,871
)
 
$
7,449

Condensed Consolidating Statements of Cash Flow
Condensed Statements of Cash Flows
 
Year Ended December 31,
 
2017
 
2016
 
2015
 
(In millions)
Operating activities:
 
 
 
 
 
Net cash provided by operating activities
$
166

 
$
55

 
$
113

Investing activities:
 
 
 
 
 

Capital contributions to subsidiaries
(370
)
 
(386
)
 
(770
)
Dividends received from subsidiaries
286

 
101

 
142

Purchases of investments
(352
)
 
(115
)
 
(244
)
Proceeds from sales and maturities of investments
168

 
188

 
118

Purchases of property, equipment and capitalized software
(67
)
 
(125
)
 
(91
)
Change in amounts due to/from affiliates
(49
)
 
(18
)
 
(68
)
Other, net

 
6

 

Net cash used in investing activities
(384
)
 
(349
)
 
(913
)
Financing activities:
 
 
 
 
 

Proceeds from senior notes offerings, net of issuance costs
325

 

 
689

Proceeds from borrowings under credit facility
300

 

 

Proceeds from common stock offering, net of issuance costs

 

 
373

Proceeds from employee stock plans
19

 
18

 
18

Cash paid for financing transaction fees
(7
)
 

 

Other, net
(1
)
 
2

 
5

Net cash provided by financing activities
636

 
20

 
1,085

Net increase (decrease) in cash and cash equivalents
418

 
(274
)
 
285

Cash and cash equivalents at beginning of year
86

 
360

 
75

Cash and cash equivalents at end of year
$
504

 
$
86

 
$
360

MOLINA HEALTHCARE, INC.
CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS
 
Year Ended December 31, 2017
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Operating activities:
 
 
 
 
 
 
 
 
 
Net cash provided by operating activities
$
166

 
83

 
555

 

 
$
804

Investing activities:
 
 
 
 
 
 
 
 
 
Purchases of investments
(352
)
 

 
(2,366
)
 

 
(2,718
)
Proceeds from sales and maturities of investments
168

 

 
1,603

 

 
1,771

Purchases of property, equipment and capitalized software
(67
)
 
(11
)
 
(8
)
 

 
(86
)
Increase in restricted investments

 

 
(12
)
 

 
(12
)
Capital contributions to subsidiaries
(370
)
 
2

 
368

 

 

Dividends received from subsidiaries
286

 
(25
)
 
(261
)
 

 

Change in amounts due to/from affiliates
(49
)
 
1

 
48

 

 

Other, net

 
(28
)
 

 

 
(28
)
Net cash used in by investing activities
(384
)
 
(61
)
 
(628
)
 

 
(1,073
)
Financing activities:
 
 
 
 
 
 
 
 
 
Proceeds from senior notes offering, net of issuance costs
325

 

 

 

 
325

Proceeds from borrowings under credit facility
300

 

 

 

 
300

Proceeds from employee stock plans
19

 

 

 

 
19

Cash paid for financing transaction fees
(7
)
 

 

 

 
(7
)
Other, net
(1
)
 

 

 

 
(1
)
Net cash provided by financing activities
636

 

 

 

 
636

Net increase (decrease) in cash and cash equivalents
418

 
22

 
(73
)
 

 
367

Cash and cash equivalents at beginning of period
86

 
6

 
2,727

 

 
2,819

Cash and cash equivalents at end of period
$
504

 
$
28

 
$
2,654

 
$

 
$
3,186

 
Year Ended December 31, 2016
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Operating activities:
 
 
 
 
 
 
 
 
 
Net cash provided by operating activities
$
55

 
48

 
570

 

 
$
673

Investing activities:
 
 
 
 
 
 
 
 
 
Purchases of investments
(115
)
 

 
(1,814
)
 

 
(1,929
)
Proceeds from sales and maturities of investments
188

 

 
1,778

 

 
1,966

Purchases of property, equipment and capitalized software
(125
)
 
(29
)
 
(22
)
 

 
(176
)
Decrease in restricted investments

 

 
4

 

 
4

Net cash paid in business combinations

 
(5
)
 
(43
)
 

 
(48
)
Capital contributions to subsidiaries
(386
)
 
7

 
379

 

 

Dividends received from subsidiaries
101

 

 
(101
)
 

 

Change in amounts due to/from affiliates
(18
)
 
(2
)
 
20

 

 

Other, net
6

 
(26
)
 
1

 

 
(19
)
Net cash (used in) provided by investing activities
(349
)
 
(55
)
 
202

 

 
(202
)
Financing activities:
 
 
 
 
 
 
 
 
 
Proceeds from employee stock plans
18

 

 

 

 
18

Other, net
2

 

 
(1
)
 

 
1

Net cash provided by financing activities
20

 

 
(1
)
 

 
19

Net (decrease) increase in cash and cash equivalents
(274
)
 
(7
)
 
771

 

 
490

Cash and cash equivalents at beginning of period
360

 
13

 
1,956

 

 
2,329

Cash and cash equivalents at end of period
$
86

 
$
6

 
$
2,727

 
$

 
$
2,819


 
Year Ended December 31, 2015
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Operating activities:
 
 
 
 
 
 
 
 
 
Net cash provided by operating activities
$
113

 
51

 
961

 

 
$
1,125

Investing activities:
 
 
 
 
 
 
 
 
 
Purchases of investments
(244
)
 

 
(1,679
)
 

 
(1,923
)
Proceeds from sales and maturities of investments
118

 

 
1,008

 

 
1,126

Purchases of property, equipment and capitalized software
(91
)
 
(20
)
 
(21
)
 

 
(132
)
Decrease in restricted investments

 
5

 
(11
)
 

 
(6
)
Net cash paid in business combinations

 
(174
)
 
(276
)
 

 
(450
)
Capital contributions to subsidiaries
(770
)
 
236

 
534

 

 

Dividends received from subsidiaries
142

 

 
(142
)
 

 

Change in amounts due to/from affiliates
(68
)
 
(63
)
 
131

 

 

Other, net

 
(35
)
 

 

 
(35
)
Net cash used in investing activities
(913
)
 
(51
)
 
(456
)
 

 
(1,420
)
Financing activities:
 
 
 
 
 
 
 
 
 
Proceeds from senior notes offerings, net of issuance costs
689

 

 

 

 
689

Proceeds from common stock offering, net of issuance costs
373

 

 

 

 
373

Proceeds from employee stock plans
18

 

 

 

 
18

Other, net
5

 

 

 

 
5

Net cash provided by financing activities
1,085

 

 

 

 
1,085

Net increase in cash and cash equivalents
285

 

 
505

 

 
790

Cash and cash equivalents at beginning of period
75

 
13

 
1,451

 

 
1,539

Cash and cash equivalents at end of period
$
360

 
$
13

 
$
1,956

 
$

 
$
2,329